This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Gary O. Caviness: Innovator in Molecular Identification
Introduction
Gary O. Caviness is a notable inventor based in Danbury, CT (US). He has made significant contributions to the field of molecular identification, particularly in relation to the LFA-1 receptor. His work has implications for understanding receptor occupancy and the development of therapeutic molecules.
Latest Patents
Gary O. Caviness holds a patent titled "Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy." This invention relates to a method for identifying molecules that bind the R7.1 epitope of LFA-1 or bind LFA-1 in a way that modifies the R7.1 epitope. The patent also describes methods for determining the occupancy of the LFA-1 receptor by these molecules after administration to a subject. This innovative approach has the potential to advance research in receptor biology and therapeutic development.
Career Highlights
Caviness is associated with Boehringer Ingelheim Pharmaceuticals, Inc., where he applies his expertise in molecular biology and pharmacology. His work at this leading pharmaceutical company allows him to contribute to the development of new therapies and enhance our understanding of molecular interactions.
Collaborations
Some of his notable coworkers include Joseph R. Woska, Jr. and Robert Rothlein. Their collaborative efforts in research and development have furthered advancements in the field of molecular identification.
Conclusion
Gary O. Caviness is a distinguished inventor whose work in molecular identification has significant implications for therapeutic development. His contributions continue to influence the field and pave the way for future innovations.